Indonesia signs agreement with Sinovac for Covid-19 vaccine


Sinovac has granted priority access for bulk supply to Indonesia until the end of 2020. - Reuters

JAKARTA (Bloomberg): Indonesia signed an agreement with China's Sinovac Biotech for 50 million doses of Covid-19 vaccine concentrate that will allow state-owned PT Bio Farma to produce doses locally.

Sinovac will ship the concentrate in five equal stages between November and March, vaccine maker Bio Farma said in a statement on Saturday (Aug 22).

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Indonesia , Sinovac , covid-19 , vaccine , agreement

   

Next In Aseanplus News

A chess extravaganza awaits as Singapore hosts World Chess Championship from Nov 25
Complaints on deepfake sex crimes surge in South Korea
Cricket-India win toss, bat first in series opener v Australia
China war scenario calls for US boost in defence spending to more than 3% of GDP
China resident builds fire escape door, stairs to nearby block, ordered to restore structure
Trainees urged to uphold integrity and avoid corruption, says IGP
RM1,530 for a coffee? Scottish farm sells Britain's most expensive cup of Joe
Five tourists dead, including British woman and Aussie teen, after suspected tainted alcohol poisoning in Laos
UPNM cadet claims trial to causing hurt to junior using spiked boot in latest bullying case
Political wrangling in India as US charges billionaire Gautam Adani with bribery and fraud

Others Also Read